{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:14:47Z","timestamp":1793970887269,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tata Memorial Hospital - TMC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14305-7","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T18:30:50Z","timestamp":1747852250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Study protocol of short versus long-term levetiracetam in brain tumors (LIBRA): a phase 3 randomized controlled trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Archya","family":"Dasgupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakthivel","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhana","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliasgar","family":"Moiyadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitkumar","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajari","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameya","family":"Puranik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indraja","family":"Dev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Epari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushi","family":"Sahay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aekta","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Bano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejpal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"issue":"5","key":"14305_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","volume":"6","author":"MSM van Breemen","year":"2007","unstructured":"van Breemen MSM, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6(5):421\u201330.","journal-title":"Lancet Neurol"},{"issue":"6","key":"14305_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/CCO.0000000000000876","volume":"34","author":"PB van der Meer","year":"2022","unstructured":"van der Meer PB, Taphoorn MJB, Koekkoek JAF. Management of epilepsy in brain tumor patients. Curr Opin Oncol. 2022;34(6):685\u201390.","journal-title":"Curr Opin Oncol"},{"key":"14305_CR3","doi-asserted-by":"crossref","unstructured":"Avila EK, Tobochnik S, Inati SK, Koekkoek JAF, McKhann GM, Riviello JJ et al. Brain tumor-related epilepsy management: A society for Neuro-oncology (SNO) consensus review on current management. Neuro Oncol. 2023;noad154.","DOI":"10.1093\/neuonc\/noad154"},{"issue":"2","key":"14305_CR4","first-page":"306","volume":"25","author":"AM Pack","year":"2019","unstructured":"Pack AM. Epilepsy overview and revised classification of seizures and epilepsies. Continuum (Minneap Minn). 2019;25(2):306\u201321.","journal-title":"Continuum (Minneap Minn)"},{"issue":"10","key":"14305_CR5","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S1474-4422(05)70172-1","volume":"4","author":"E Olafsson","year":"2005","unstructured":"Olafsson E, Ludvigsson P, Gudmundsson G, Hesdorffer D, Kjartansson O, Hauser WA. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol. 2005;4(10):627\u201334.","journal-title":"Lancet Neurol"},{"key":"14305_CR6","doi-asserted-by":"publisher","unstructured":"Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE et al. ILAE Official Report: A practical clinical definition of epilepsy. Epilepsia [Internet]. 2014 [cited 2023 May 28];55(4):475\u201382. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1111\/epi.12550","DOI":"10.1111\/epi.12550"},{"issue":"4","key":"14305_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, et al. ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):512\u201321.","journal-title":"Epilepsia"},{"issue":"2","key":"14305_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1212\/01.wnl.0000168903.09277.8f","volume":"65","author":"J Hildebrand","year":"2005","unstructured":"Hildebrand J, Lecaille C, Perennes J, Delattre JY. Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology. 2005;65(2):212\u20135.","journal-title":"Neurology"},{"issue":"6","key":"14305_CR9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00019052-199612000-00005","volume":"9","author":"JG Villemure","year":"1996","unstructured":"Villemure JG, de Tribolet N. Epilepsy in patients with central nervous system tumors. Curr Opin Neurol. 1996;9(6):424\u20138.","journal-title":"Curr Opin Neurol"},{"key":"14305_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/B978-0-12-802997-8.00016-5","volume":"134","author":"DJ Englot","year":"2016","unstructured":"Englot DJ, Chang EF, Vecht CJ. Epilepsy and brain tumors. Handb Clin Neurol. 2016;134:267\u201385.","journal-title":"Handb Clin Neurol"},{"key":"14305_CR11","doi-asserted-by":"publisher","first-page":"1071314","DOI":"10.3389\/fnins.2022.1071314","volume":"16","author":"M Xie","year":"2022","unstructured":"Xie M, Wang X, Duan Z, Luan G. Low-grade epilepsy-associated neuroepithelial tumors: tumor spectrum and diagnosis based on genetic alterations. Front Neurosci. 2022;16:1071314.","journal-title":"Front Neurosci"},{"issue":"6","key":"14305_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00701-004-0266-8","volume":"146","author":"SL Hwang","year":"2004","unstructured":"Hwang SL, Lin CL, Lee KS, Lieu AS, Kuo TH, Chang CZ, et al. Factors influencing seizures in adult patients with supratentorial astrocytic tumors. Acta Neurochir (Wien). 2004;146(6):589\u201394. discussion 594.","journal-title":"Acta Neurochir (Wien)"},{"issue":"9","key":"14305_CR13","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1212\/WNL.0b013e318266fa89","volume":"79","author":"TI Yuen","year":"2012","unstructured":"Yuen TI, Morokoff AP, Bjorksten A, D\u2019Abaco G, Paradiso L, Finch S, et al. Glutamate is associated with a higher risk of seizures in patients with gliomas. Neurology. 2012;79(9):883\u20139.","journal-title":"Neurology"},{"issue":"116","key":"14305_CR14","doi-asserted-by":"publisher","first-page":"116ra4","DOI":"10.1126\/scitranslmed.3002693","volume":"4","author":"OC Andronesi","year":"2012","unstructured":"Andronesi OC, Kim GS, Gerstner E, Batchelor T, Tzika AA, Fantin VR, et al. Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy. Sci Transl Med. 2012;4(116):116ra4.","journal-title":"Sci Transl Med"},{"issue":"11","key":"14305_CR15","first-page":"1559","volume":"18","author":"H Nagashima","year":"2016","unstructured":"Nagashima H, Tanaka K, Sasayama T, Irino Y, Sato N, Takeuchi Y, et al. Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma. Neuro Oncol. 2016;18(11):1559\u201368.","journal-title":"Neuro Oncol"},{"issue":"19","key":"14305_CR16","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1212\/WNL.0000000000003911","volume":"88","author":"H Chen","year":"2017","unstructured":"Chen H, Judkins J, Thomas C, Wu M, Khoury L, Benjamin CG, et al. Mutant IDH1 and seizures in patients with glioma. Neurology. 2017;88(19):1805\u201313.","journal-title":"Neurology"},{"issue":"9","key":"14305_CR17","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/neuonc\/noac003","volume":"24","author":"A Mortazavi","year":"2022","unstructured":"Mortazavi A, Fayed I, Bachani M, Dowdy T, Jahanipour J, Khan A, et al. IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation. Neuro Oncol. 2022;24(9):1423\u201335.","journal-title":"Neuro Oncol"},{"issue":"12","key":"14305_CR18","doi-asserted-by":"publisher","first-page":"e168035","DOI":"10.1172\/JCI168035","volume":"133","author":"MR Drumm","year":"2023","unstructured":"Drumm MR, Wang W, Sears TK, Bell-Burdett K, Javier R, Cotton KY, et al. Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors. J Clin Invest. 2023;133(12):e168035.","journal-title":"J Clin Invest"},{"issue":"6","key":"14305_CR19","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3171\/2015.4.JNS142742","volume":"124","author":"DJ Englot","year":"2016","unstructured":"Englot DJ, Magill ST, Han SJ, Chang EF, Berger MS, McDermott MW. Seizures in supratentorial meningioma: a systematic review and meta-analysis. J Neurosurg. 2016;124(6):1552\u201361.","journal-title":"J Neurosurg"},{"issue":"8","key":"14305_CR20","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.clinthera.2008.08.011","volume":"30","author":"KYL Yap","year":"2008","unstructured":"Yap KYL, Chui WK, Chan A. Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther. 2008;30(8):1385\u2013407.","journal-title":"Clin Ther"},{"issue":"2","key":"14305_CR21","first-page":"105","volume":"9","author":"PB van der Meer","year":"2022","unstructured":"van der Meer PB, Dirven L, van den Bent MJ, Preusser M, Taphoorn MJB, Rud\u00e1 R, et al. Prescription preferences of antiepileptic drugs in brain tumor patients: an international survey among EANO members. Neurooncol Pract. 2022;9(2):105\u201313.","journal-title":"Neurooncol Pract"},{"issue":"2","key":"14305_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.2174\/157015912800604470","volume":"10","author":"M Maschio","year":"2012","unstructured":"Maschio M. Brain tumor-related epilepsy. Curr Neuropharmacol. 2012;10(2):124\u201333.","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"14305_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneurol.2009.335","volume":"67","author":"A Rosati","year":"2010","unstructured":"Rosati A, Buttolo L, Stefini R, Todeschini A, Cenzato M, Padovani A. Efficacy and safety of Levetiracetam in patients with glioma: a clinical prospective study. Arch Neurol. 2010;67(3):343\u20136.","journal-title":"Arch Neurol"},{"issue":"5","key":"14305_CR24","first-page":"501","volume":"8","author":"ME de Bruin","year":"2021","unstructured":"de Bruin ME, van der Meer PB, Dirven L, Taphoorn MJB, Koekkoek JAF. Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review. Neurooncol Pract. 2021;8(5):501\u201317.","journal-title":"Neurooncol Pract"},{"issue":"3","key":"14305_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11060-008-9781-4","volume":"93","author":"DA Lim","year":"2009","unstructured":"Lim DA, Tarapore P, Chang E, Burt M, Chakalian L, Barbaro N, et al. Safety and feasibility of switching from phenytoin to Levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol. 2009;93(3):349\u201354.","journal-title":"J Neurooncol"},{"issue":"10231","key":"14305_CR26","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","volume":"395","author":"JM Chamberlain","year":"2020","unstructured":"Chamberlain JM, Kapur J, Shinnar S, Elm J, Holsti M, Babcock L, et al. Efficacy of Levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020;395(10231):1217\u201324.","journal-title":"Lancet"},{"issue":"4","key":"14305_CR27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/14737175.2022.2057224","volume":"22","author":"R Roberti","year":"2022","unstructured":"Roberti R, Rocca M, Iannone LF, Gasparini S, Pascarella A, Neri S, et al. Status epilepticus in pregnancy: a literature review and a protocol proposal. Expert Rev Neurother. 2022;22(4):301\u201312.","journal-title":"Expert Rev Neurother"},{"key":"14305_CR28","doi-asserted-by":"crossref","unstructured":"Cucchiara F, Pasqualetti F, Giorgi FS, Danesi R, Bocci G. Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours? Pharmacological Research [Internet]. 2020 Jun 1 [cited 2023 Oct 8];156:104786. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1043661820302851","DOI":"10.1016\/j.phrs.2020.104786"},{"issue":"7","key":"14305_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1200\/JCO.2015.63.6563","volume":"34","author":"C Happold","year":"2016","unstructured":"Happold C, Gorlia T, Chinot O, Gilbert MR, Nabors LB, Wick W, et al. Does valproic acid or Levetiracetam improve survival in glioblastoma?? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma?. J Clin Oncol. 2016;34(7):731\u20139.","journal-title":"J Clin Oncol"},{"issue":"1","key":"14305_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000052089","volume":"45","author":"A Liigant","year":"2001","unstructured":"Liigant A, Haldre S, Oun A, Linnam\u00e4gi U, Saar A, Asser T, et al. Seizure disorders in patients with brain tumors. Eur Neurol. 2001;45(1):46\u201351.","journal-title":"Eur Neurol"},{"issue":"4","key":"14305_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jpainsymman.2018.07.012","volume":"56","author":"P Howard","year":"2018","unstructured":"Howard P, Remi J, Remi C, Charlesworth S, Whalley H, Bhatia R, et al. Levetiracetam J Pain Symptom Manage. 2018;56(4):645\u20139.","journal-title":"Levetiracetam J Pain Symptom Manage"},{"issue":"11","key":"14305_CR32","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/neuonc\/noab152","volume":"23","author":"T Walbert","year":"2021","unstructured":"Walbert T, Harrison RA, Schiff D, Avila EK, Chen M, Kandula P, et al. SNO and EANO practice guideline update: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neuro Oncol. 2021;23(11):1835\u201344.","journal-title":"Neuro Oncol"},{"issue":"1","key":"14305_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1227\/neu.0000000000002164","volume":"92","author":"M Rahman","year":"2023","unstructured":"Rahman M, Eisenschenk S, Melnick K, Wang Y, Heaton S, Ghiaseddin A, et al. Duration of prophylactic Levetiracetam after surgery for brain tumor: A prospective randomized trial. Neurosurgery. 2023;92(1):68\u201374.","journal-title":"Neurosurgery"},{"issue":"Supplement5","key":"14305_CR34","first-page":"v106","volume":"26","author":"MD Jenkinson","year":"2024","unstructured":"Jenkinson MD, Bulbeck H, Rooney A, Thompson G, Burns J, Robinson T, et al. P18.39. A seizure prophylaxis in glioma surgery (SPRING): A multi-centre, unblinded, randomised trial. Neurooncology. 2024;26(Supplement5):v106.","journal-title":"Neurooncology"},{"issue":"Suppl 2","key":"14305_CR35","doi-asserted-by":"publisher","first-page":"ii195","DOI":"10.1093\/neuonc\/noaa215.815","volume":"22","author":"M Jenkinson","year":"2020","unstructured":"Jenkinson M, Helmy A, Huckey H, Mills S, Grant R, Hughes D, et al. RTID-10. Surgeons trial of prophylaxis for epilepsy in seizure na\u00efve patients with meningioma: a randomized controlled trial (STOP \u2018EM). Neuro Oncol. 2020;22(Suppl 2):ii195.","journal-title":"Neuro Oncol"},{"issue":"3","key":"14305_CR36","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11060-023-04450-z","volume":"164","author":"PB van der Meer","year":"2023","unstructured":"van der Meer PB, Dirven L, Fiocco M, Vos MJ, Kerkhof M, Kouwenhoven MCM, et al. Impact of timing of Antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study. J Neurooncol. 2023;164(3):545\u201355.","journal-title":"J Neurooncol"},{"issue":"3","key":"14305_CR37","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s11060-019-03117-y","volume":"142","author":"M Kerkhof","year":"2019","unstructured":"Kerkhof M, Koekkoek JaF, Vos MJ, van den Bent MJ, Taal W, Postma TJ, et al. Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study. J Neurooncol. 2019;142(3):463\u201370.","journal-title":"J Neurooncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14305-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14305-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14305-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T18:30:56Z","timestamp":1747852256000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14305-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14305"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14305-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is being conducted in accordance with ICMR (2017) \u201cNational Ethical Guidelines for Biomedical and Health Research Involving Human Participants, International Conference on Harmonization Good Clinical Practice (ICH-GCP) guidelines, Good Clinical Practice and the principles of the Declaration of Helsinki. The study, including all the study-related documents, has obtained approval from the Ethics Committee prior to the enrolment of participants. The trial has been registered with Clinical Trial Registry of India (CTRI\/2024\/06\/069498) and Clinicaltrials.gov (study identifier NCT06442748).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All the study investigators declare no conflict of interest in the conduct or outcome of the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"911"}}